Haidong Gao

Haidong Gao


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2018 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
YTYawen Tan
Yawen Tan
GZGuanglin Zhou
Guanglin Zhou
XWXianming Wang
Xianming Wang
WCWeicai Chen
Weicai Chen
HGHaidong Gao
Haidong Gao
Recent studies have suggested that ubiquitin-specific peptidase (USP)18 may act as an oncogene in various types of cancer. Although the role of USP18 in breast cancer cell lines has been elucidated, the underlying mechanisms and clinical role of USP18 in breast cancer are currently not well understood. The bioinformatics analysis and experimental results of the present study demonstrated that aberrant promoter methylation led to increased expression of USP18 in breast cancer. In addition, correlation analysis suggested that a negative correlation between methylation and USP18 mRNA expression was observed in The Cancer Genome Atlas database. USP18 promoted cell proliferation, colony formation and cell cycle progression in vitro. Furthermore, the Gene Set Enrichment Analysis results demonstrated that USP18 may be negatively associated with apoptosis in patients with breast cancer. Bioinformatics analysis results indicated that USP18 was also revealed to be associated with the protein kinase B (AKT) signaling pathway and mammary tumorigenesis in vivo. In addition, the results indicated that USP18 may promote the epidermal growth factor (EGF)-mediated EGF receptor (EGFR)/AKT/S‑phase kinase-associated protein 2 (Skp2) pathway by upregulating EGFR and Skp2 in a AKT/forkhead box O3-dependent manner in breast cancer. The results of bioinformatics analysis revealed that increased USP18 expression was associated with a higher TNM stage and unfavorable prognosis in clinical patients. USP18 was also significantly enhanced in patients with human epidermal growth factor receptor 2-positive breast cancer; furthermore, Kaplan‑Meier curve demonstrated that combining USP18 and Skp2 expression improved prognostic capability in breast cancer. Taken together, these results suggested that USP18 may serve a key role in breast cancer development by upregulating EGFR and subsequently activating the AKT/Skp2 feedback loop pathway. The role of USP18 in breast cancer provides a novel insight into the clinical application of the USP18/AKT/Skp2 pathway.

20 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YLYanrong Lv
Yanrong Lv
SSShanshan Song
Shanshan Song
KZKai Zhang
Kai Zhang
HGHaidong Gao
Haidong Gao
RMRong Ma
Rong Ma
A number of studies have shown that apoptosis resistance can be observed in multiple human tumors; however the detailed mechanism remains unclear. In the present study, we demonstrated that the abnormal overexpression of the C terminus of Hsc70-interacting protein (CHIP) induced apoptosis resistance by regulating the AKT/FoxO/Bim signaling pathway in the breast cancer cell MCF7 and the human non-tumorigenic cell MCF10A. We found that CHIP overexpression in MCF7 and MCF10A cells activated AKT and inhibited the Forkhead box O (FoxO) transcription factors FoxO1, FoxO3, and FoxO4, thereby inhibiting transcription of the target genes bim and pten. Inhibition of PI3K by a chemical reagent revealed that these events may be critical for CHIP-induced apoptosis resistance. We also determined that inhibition of FoxO3 by CHIP led to the decrease in PTEN and further activated the AKT survival pathway. We corroborated our findings in breast cancer tissues. In general, the CHIP-modulated AKT/FoxO/Bim signaling pathway was shown to induce apoptosis resistance by decreasing the protein level of the tumor suppressor PTEN in both transcriptional and post-translational regulations.

26 February 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YZYing Zhang
Ying Zhang
YLYanrong Lv
Yanrong Lv
YZYongyang Zhang
Yongyang Zhang
HGHaidong Gao
Haidong Gao
P53 is possibly the most important mammalian tumor suppressor and it is mutated or lost in more than half of all human cancers. The stability of p53 is primarily determined by the RING domain E3 ubiquitin ligase Hdm2, which targets p53 for proteasomal degradation, restraining the potent activity of p53 and enabling cell survival and proliferation. UBE4B has been shown to physically interact with p53 and Hdm2 and to negatively regulate p53 stability and function. However, no one has determined whether UBE4B promotes p53 degradation in breast cancer. In this study, UBE4B promoted the degradation and ubiquitination of p53 to inhibit the apoptosis of cancer cells and promote tumorigenesis. Our results indicate that UBE4B regulates p53 in breast cancer and could be a viable target for developing new therapeutic strategies for breast cancer treatment.

31 October 2013 in BMB Reports
Verified
Journal Article
Open access
YZYing Zhang
Ying Zhang
HGHaiyan Gao
Haiyan Gao
HGHaidong Gao
Haidong Gao
The phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a tumor-suppressing lipid phosphatase that is frequently absent in breast tumors. Thus, the stability of PTEN is essential for tumor prevention and therapy. The ubiquitinproteasome pathway has an important role in regulating the functions of PTEN. Specifically, carboxyl terminus Hsp70-interacting protein (CHIP), the E3 ubiquitin ligase of PTEN, can regulate PTEN levels. In this study, we report that BCL-2- associated athanogene 5 (BAG5), a known inhibitor of CHIP activity, reduces the degradation of PTEN and maintains its levels via an ubiquitylation-dependent pathway. BAG5 is identified as an antagonist of cell tumorigenicity. [BMB Reports 2013; 46(10): 490-494]

8 March 2012 in Cancer Science
Verified
Journal Article
Open access
PDF file
CXChan Xiang
Chan Xiang
HGHaidong Gao
Haidong Gao
LMLei Meng
Lei Meng
ZQZhaoyu Qin
Zhaoyu Qin
RMRong Ma
Rong Ma
HWHaijian Wang
Haijian Wang
Genetic polymorphisms in the signalling pathway of estrogen receptor (ER) could modify the risk of breast cancer. A variable number of tandem repeats (VNTR) polymorphism in the promoter of PTTG1IP, pituitary tumor transforming gene binding factor targeted by estrogen receptor α (ERα) in endocrine neoplasia, has been shown to be functional, but its relevance to cancer etiology was unknown. We investigated its association with breast cancer risk by genotyping in 658 patients and 866 controls and further analysed its differential interaction with ERα. We found nine types of alleles ranging from 2 to 9 and 11 repeats that form 29 distinct genotypes and 11 different biallelic repeat numbers. Subjects who carry the six‐repeats allele (odds ratio [OR], 1.45; 95% confidence interval [CI], 1.17–1.79), long alleles (≥6 repeats) (OR, 1.55; 95% CI, 1.17–2.05) or a high dose of biallelic repeats (OR, 1.38; 95% CI, 1.07–1.77) were at significantly increased risk of cancer. In stratification analysis, these associations consistently manifested in ER‐positive breast cancer: in ER positive, PR‐positive subtype, genotypes with the six‐repeats allele (OR, 1.42; 95% CI, 1.06–1.90), long alleles (OR, 1.77; 95% CI, 1.17–2.67) or a high dose of biallelic repeats (OR, 1.67; 95% CI, 1.19–2.33) were associated with cancer risk; in ER positive, HER2‐negative subtype, they were susceptible factors with the ORs being 1.46 (95% CI, 1.06–2.02), 2.06 (95% CI, 1.28–3.32) and 1.85 (95% CI, 1.26–2.71), respectively. Furthermore, functional analysis revealed that an increase in the number of tandem repeats enhances the binding affinity of ERα. The present study provides the first epidemiological evidence that functional regulatory variants of PTTG1IP were associated with the risk of ER‐positive breast cancer, further supporting its relevance as one proto‐oncogene in breast cancer. (Cancer Sci 2012; 103: 1121–1128)

1 April 2003
Verified
Journal Article
Closed access
HGHaidong Gao
Haidong Gao
JSJing-Zhong Sun
Jing-Zhong Sun
DBDong-Song Bi
Dong-Song Bi
RMRong Ma
Rong Ma